CN102631582A - Natural medicament for treating hypertension - Google Patents
Natural medicament for treating hypertension Download PDFInfo
- Publication number
- CN102631582A CN102631582A CN2012101293246A CN201210129324A CN102631582A CN 102631582 A CN102631582 A CN 102631582A CN 2012101293246 A CN2012101293246 A CN 2012101293246A CN 201210129324 A CN201210129324 A CN 201210129324A CN 102631582 A CN102631582 A CN 102631582A
- Authority
- CN
- China
- Prior art keywords
- treatment
- natural medicament
- percent
- medicament
- hypertension
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a natural medicament for treating hypertension, belonging to the technical field of processing of natural medicaments. The natural medicament is prepared by adopting the following steps of: 1, weighing the following materials of 15-25 percent of sunflower leaf or plate, 14-21 percent of corn stigma, 10-18 percent of digua fig stem, 6-13 percent of folium mori, 3-11 percent of pericarpium granati and 22-40 percent of water according to the proportion for later use; and 2, crushing all raw materials until the particle size reaches 100-200 meshes, adding water for soaking for 1-2h, heating to 100-110 DEG C, continuously decocting for 10-15min, filter-pressing for solid-liquid separation, and collecting filtrate to obtain the natural medicament. The natural medicament for treating hypertension has effects of recuperating and treating hypertension, has remarkable effects for treating cardiovascular diseases, cerebral thrombosis, coronary heart disease and atherosclerosis caused by the hypertension, and has the advantages of simple and convenient processing method, low production cost, environmental friendliness and no toxic or side effects.
Description
Technical field
The invention belongs to natural Chinese formulated products processing technique field, be specifically related to the hypertensive natural medicament of a kind of treatment.
Background technology
Hypertension is meant that under quiescent condition SAP and/or diastolic pressure increase (>=140/90mmHg), is not using under the antihypertensive situation, and systolic pressure >=139mmHg and/or diastolic pressure >=89mmHg are divided into 1,2 by blood pressure level with hypertension, 3 grades.<90mmHg is single-row to be isolated systolic hypertension for systolic pressure>=140mmHg and diastolic pressure.The patient previously has history of hypertension, is using antihypertensive at present, though blood pressure is lower than 140/90mmHg, also should be diagnosed as hypertension.It is the important risk factor of cardiovascular and cerebrovascular disease, often with organ dysfunction property or organic changes such as fat and sugar metabolism disorder and the heart, brain, kidney and retinas.The Along with people's living standard improve constantly the continuous change with life style; Attention to hypertension prevention and treatment is not enough; Its sickness rate and prevalence are constantly soaring, because the part hyperpietic does not have tangible clinical symptoms, and hypertension be otherwise known as " the invisible killer " of human health; It causes cardiovascular and cerebrovascular disease to become the important cause of disease that China dies of illness in the recent period and disables, is seriously threatening people's quality of life and life and health.
That metabolism syndrome is meant is overweight, hypertension, glycolipid metabolism is unusual and the patient of multiple Developmental and Metabolic Disorder such as insulin resistant.Over year, China's hypertension sickness rate constantly raises surplus in the of nearly ten, and sickness rate fat and that glycolipid metabolism is disorderly also increases fast.Epidemiological study finds that in the hypertension sufferer, the prevalence of metabolism syndrome accounts for more than 47%, and the sickness rate of these people's cardiovascular disease significantly increases, and people's health in serious threat.It is also more and more common that hypertension merges various forms of metabolism disorders clinically, and target organ damages such as its heart that causes, brain, kidney, blood vessel also become increasingly complex and seriously.Patients with hypertension more than 80% is associated with the disease of metabolism syndrome simultaneously, and hypertension companion metabolism syndrome is higher than the risk of simple patients with hypertension generation cardiovascular and cerebrovascular disease.1998, China's cerebrovascular occupied second of urbanite's cause of death, ranks first in the rural area.The whole nation is annual dead to surpass 1,000,000, and the patient of survival is about 5,000,000~6,000,000, wherein leaves deformity in various degree more than 75%, has caused white elephant for individual, family and society.And the main hazard factor of apoplexy is a hypertension.Simultaneously, hypertension still is the fuse cord of multiple disease, and the onset risk of diseases such as coronary heart disease, heart failure and kidney disease is increased.And can influence each other between various metabolism disorders in the metabolism syndrome and the hypertension, therefore improve understanding to hypertension, early prevention, treatment in time there are extremely important meaning.Be combined the treatment of the patients with hypertension of metabolism syndrome, modern medicine advocates outside the blood pressure lowering treatment, also must carry out the integral body intervention to it.Chinese medicine has the characteristics of organic conception and determination of treatment based on pathogenesis obtained through differentiation of symptoms and signs, along with deepening continuously of research, merges the metabolism syndrome this respect in the treatment hypertension and has demonstrated special advantages.Over nearly 20 years along with modern medicine to hypertension research progressively deeply, have recognized that at present hypertension is one and can produces the clinical syndrome of multiple cardiovascular infringement by due to the multiple risk factor, hypertension is wherein one of to show.Medical circle proposes the research of hypertension should not be limited to the adjusting and the hypertensive control of blood pressure for this reason, causes hypertensive many cardiovascular and metabolic risk factors and should pay close attention to more widely.
Summary of the invention
To the problems referred to above that exist in the prior art, the objective of the invention is to design provide a kind of treat hypertensive natural medicament and its production and use technical scheme, it is low to have a cost, effect is remarkable, natural environmental-protective, advantage such as without any side effects.
The hypertensive natural medicament of described a kind of treatment is characterized in that adopting following method preparation:
1) proportionally take by weighing the following material of weight percentage: sunflower leaf or dish 15-25%, Stigma Maydis 14-21%, Fructus Fici tikouae root 10-18%, Folium Mori 6-13%, Pericarpium Granati 3-11%, water 22-40%, subsequent use;
2) then with all pulverizing medicinal materials to the 100-200 order, soaked 1-2 hour, reheat continue to decoct 10~15min to 100-110 ℃, filter pressing is carried out solid-liquid separation and is removed dregs, collects the filtrating part,, final products.
The hypertensive natural medicament of described a kind of treatment is characterized in that described sunflower leaf or (dish) content are 16-23%, is preferably 18-21%.
The hypertensive natural medicament of described a kind of treatment is characterized in that described Stigma Maydis content is 15-20%, is preferably 16-18%.
The hypertensive natural medicament of described a kind of treatment is characterized in that described Fructus Fici tikouae radical content is 12-17%, is preferably 13-15%.
The hypertensive natural medicament of described a kind of treatment is characterized in that described Folium Mori content is 8-11%, is preferably 9-10%.
The hypertensive natural medicament of described a kind of treatment is characterized in that described Pericarpium Granati content is 5-10%, is preferably 7-9%.
The hypertensive natural medicament of described a kind of treatment is characterized in that described water content is 25-38%, is preferably 27-37%.
The hypertensive natural medicament of described a kind of treatment, it is characterized in that: all medical material times of soaking are 1.5-1.8 hour, are heated to 105-108 ℃ and continue to decoct 12~14min.
The hypertensive natural medicament of above-mentioned a kind of treatment; With pure natural plants and medical herbs is that active ingredient is processed, and has conditioning, treatment hypertension, the comprehensive vascular morphology that improves; Make vascular patency; Blood pressure reduces, and lets patient's blood pressure level recover normal level, and cardio-cerebralvascular diseases, cerebral thrombosis, coronary heart disease, the atherosclerosis that is caused by hypertension all had obvious effects.Its simple and convenient processing method, equipment investment is few, and raw material sources are guaranteed, energy efficient, storing and application safety, low production cost, natural environmental-protective and without any side effects, long-term efficacy obviously is superior to taking Western medicine.
The percentage composition that relates in the present specification unless otherwise indicated, other the weight percentage that is pure material.
The specific embodiment
Combine embodiments of the invention at present, further specify beneficial effect of the present invention.
Embodiment 1
With sunflower leaf, Stigma Maydis, Fructus Fici tikouae root, Folium Mori, Pericarpium Granati pulverize separately to 100 order; In the 500L stirred tank, drop into 185kg water then, sunflower leaf, 80kg Stigma Maydis, 65kg Fructus Fici tikouae root, 45kg Folium Mori and 35kg Pericarpium Granati after 90kg pulverizes stir then and soaked 1.5 hours; Reheat to the 100 ℃ lasting 15min that decocts; At last solid-liquid separation is carried out in the filter pressing of gained reactant and removes dregs, collect the filtrating part, final products.
Embodiment 2
With Receptaculum Helianthi, Stigma Maydis, Fructus Fici tikouae root, Folium Mori, Pericarpium Granati pulverize separately to 200 order; In the 500L stirred tank, drop into 135kg water then, sunflower leaf dish, 90kg Stigma Maydis, 75kg Fructus Fici tikouae root, 50kg Folium Mori and 45kg Pericarpium Granati after 105kg pulverizes stir then and soaked 2 hours; Reheat to the 110 ℃ lasting 10min that decocts; At last solid-liquid separation is carried out in the filter pressing of gained reactant and removes dregs, collect the filtrating part, final products.
Embodiment 3
With sunflower leaf, Stigma Maydis, Fructus Fici tikouae root, Folium Mori, Pericarpium Granati pulverize separately to 150 order; In the 500L stirred tank, drop into 170kg water then, sunflower leaf, 82kg Stigma Maydis, 70kg Fructus Fici tikouae root, 48kg Folium Mori and 38kg Pericarpium Granati after 92kg pulverizes stir then and soaked 1 hour; Reheat to the 105 ℃ lasting 12min that decocts; At last solid-liquid separation is carried out in the filter pressing of gained reactant and removes dregs, collect the filtrating part, final products.
Embodiment 4
With sunflower leaf, Stigma Maydis, Fructus Fici tikouae root, Folium Mori, Pericarpium Granati pulverize separately to 200 order; In the 500L stirred tank, drop into 158kg water then, sunflower leaf, 84kg Stigma Maydis, 72kg Fructus Fici tikouae root, 46kg Folium Mori and 40kg Pericarpium Granati after 100kg pulverizes stir then and soaked 1.8 hours; Reheat to the 108 ℃ lasting 13min that decocts; At last solid-liquid separation is carried out in the filter pressing of gained reactant and removes dregs, collect the filtrating part, final products.
Embodiment 5
With Receptaculum Helianthi, Stigma Maydis, Fructus Fici tikouae root, Folium Mori, Pericarpium Granati pulverize separately to 100 order; In the 500L stirred tank, drop into 154kg water then, Receptaculum Helianthi, 86kg Stigma Maydis, 68kg Fructus Fici tikouae root, 47kg Folium Mori and 42kg Pericarpium Granati after 103kg pulverizes stir then and soaked 1.6 hours; Reheat to the 110 ℃ lasting 11min that decocts; At last solid-liquid separation is carried out in the filter pressing of gained reactant and removes dregs, collect the filtrating part, final products.
Embodiment 6
With sunflower leaf, Stigma Maydis, Fructus Fici tikouae root, Folium Mori, Pericarpium Granati pulverize separately to 200 order; In the 500L stirred tank, drop into 150kg water then, sunflower leaf, 88kg Stigma Maydis, 74kg Fructus Fici tikouae root, 49kg Folium Mori and 44kg Pericarpium Granati after 95kg pulverizes stir then and soaked 2 hours; Reheat to the 100 ℃ lasting 15min that decocts; At last solid-liquid separation is carried out in the filter pressing of gained reactant and removes dregs, collect the filtrating part, final products.
Below through concrete test explanation beneficial effect of the present invention
Test one:
Each processing selects 50 routine patients to make an experiment respectively, wherein male 30 examples, women 20 examples; 35~72 years old age, average 55.3 years old; Average course of disease 12.6.The diagnostic criteria that all patient diagnosis all meet national cardiovascular disease control meeting reaches condition by stages.Diagnostic criteria: blood pressure continue or>3 non-systolic pressure >=140mmHg on the same day (1mmHg=0.1333kPa) and (or) diastolic pressure >=90mmHg is diagnosable hypertension.Therapeutic Method: get one bottle of the medicament of embodiment 1-6 gained, every bottle of about 150ml took three times on the 1st, and each one bottle, 20 days is 1 course of treatment, advises the patient to strike a proper balance between work and rest simultaneously, and limit salt is careful in one's diet, and controlling body weight strengthens physical training, wine for giving off smoking etc.Test and check after 2 months, statistics produce effects, effective, invalid sufferer number calculate its total effective rate (%), and clinical observation simultaneously has or not the hypertension complication takes place.Criterion of therapeutical effect: with reference to " the clinical drug research guideline " of Ministry of Public Health promulgation.1. produce effects: diastolic pressure decline >=10mmHg also reduces to normal, or the above person of decline 20mmHg; 2. effective: diastolic pressure descends and does not reach 10mmHg, but has reduced to normally, or descend 10~19mmHg or systolic pressure decline >=30mmHg; 3. invalid: as not reach above-mentioned horizontal person.Result of the test is seen table 1.
Table 1 embodiment 1-6 is to hypertensive test effect
Handle | Sufferer (example) | Produce effects | Effectively | Invalid | Total effective rate (%) |
Embodiment 1 | 50 | 15 | 34 | 1 | 98 |
Embodiment 2 | 50 | 21 | 29 | 0 | 100 |
Embodiment 3 | 50 | 17 | 33 | 0 | 100 |
Embodiment 4 | 50 | 17 | 31 | 2 | 96 |
Embodiment 5 | 50 | 20 | 29 | 1 | 98 |
Embodiment 6 | 50 | 23 | 27 | 0 | 100 |
Result of the test shows: embodiment 1-6 all has better curative effect to hypertension, and embodiment 2 is superior to embodiment 1, and embodiment 3 is superior to embodiment 4, and embodiment 6 is superior to embodiment 5, and the hypertension complication appears in none example.
Claims (8)
1. treat hypertensive natural medicament for one kind, it is characterized in that adopting following method preparation:
1) proportionally take by weighing the following material of weight percentage: sunflower leaf or dish 15-25%, Stigma Maydis 14-21%, Fructus Fici tikouae root 10-18%, Folium Mori 6-13%, Pericarpium Granati 3-11%, water 22-40%, subsequent use;
2) then with all pulverizing medicinal materials to the 100-200 order, soaked 1-2 hour, reheat continue to decoct 10~15min to 100-110 ℃, filter pressing is carried out solid-liquid separation and is removed dregs, collects the filtrating part, final products.
2. the hypertensive natural medicament of a kind of treatment as claimed in claim 1 is characterized in that described sunflower leaf or dish content are 16-23%, is preferably 18-21%.
3. the hypertensive natural medicament of a kind of treatment as claimed in claim 1 is characterized in that described Stigma Maydis content is 15-20%, is preferably 16-18%.
4. the hypertensive natural medicament of a kind of treatment as claimed in claim 1 is characterized in that described Fructus Fici tikouae radical content is 12-17%, is preferably 13-15%.
5. the hypertensive natural medicament of a kind of treatment as claimed in claim 1 is characterized in that described Folium Mori content is 8-11%, is preferably 9-10%.
6. the hypertensive natural medicament of a kind of treatment as claimed in claim 1 is characterized in that described Pericarpium Granati content is 5-10%, is preferably 7-9%.
7. the hypertensive natural medicament of a kind of treatment as claimed in claim 1 is characterized in that described water content is 25-38%, is preferably 27-37%.
8. the hypertensive natural medicament of a kind of treatment as claimed in claim 1, it is characterized in that: all medical material times of soaking are 1.5-1.8 hour, are heated to 105-108 ℃ and continue to decoct 12~14min.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210129324.6A CN102631582B (en) | 2012-04-28 | 2012-04-28 | Natural medicament for treating hypertension |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210129324.6A CN102631582B (en) | 2012-04-28 | 2012-04-28 | Natural medicament for treating hypertension |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102631582A true CN102631582A (en) | 2012-08-15 |
CN102631582B CN102631582B (en) | 2015-01-21 |
Family
ID=46616264
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210129324.6A Expired - Fee Related CN102631582B (en) | 2012-04-28 | 2012-04-28 | Natural medicament for treating hypertension |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102631582B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103109944A (en) * | 2012-09-25 | 2013-05-22 | 刘耀昌 | Healthcare tea bagged in teabag and method for preparing same |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101401910A (en) * | 2008-09-23 | 2009-04-08 | 罗先德 | Medicament for treating hypertension |
CN101461901A (en) * | 2007-12-18 | 2009-06-24 | 丁月芳 | Bagged medicine tea for diabetes |
CN101972417A (en) * | 2010-07-21 | 2011-02-16 | 金代田 | Medicine for treating hypertension |
-
2012
- 2012-04-28 CN CN201210129324.6A patent/CN102631582B/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101461901A (en) * | 2007-12-18 | 2009-06-24 | 丁月芳 | Bagged medicine tea for diabetes |
CN101401910A (en) * | 2008-09-23 | 2009-04-08 | 罗先德 | Medicament for treating hypertension |
CN101972417A (en) * | 2010-07-21 | 2011-02-16 | 金代田 | Medicine for treating hypertension |
Non-Patent Citations (2)
Title |
---|
耀华: "治疗高血压的民间偏验方", 《山西老年》 * |
陈仁寿主编: "石榴皮", 《新编临床中药学》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103109944A (en) * | 2012-09-25 | 2013-05-22 | 刘耀昌 | Healthcare tea bagged in teabag and method for preparing same |
Also Published As
Publication number | Publication date |
---|---|
CN102631582B (en) | 2015-01-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103478539B (en) | Traditional Chinese medicine flour and application thereof | |
CN103461788B (en) | Flour compound suitable for hypertensive disease patients | |
CN102125127B (en) | Functional highland barley red yeast rice tea and preparation method thereof | |
CN102793238A (en) | Health beverage for preventing hypertension and hyperlipidemia | |
CN105920439A (en) | Effective part composition containing corn stigma extract and preparation method and application of effective part composition | |
CN102631582B (en) | Natural medicament for treating hypertension | |
CN101904501B (en) | Functional food for relieving fatigue and preparation method thereof | |
CN103393749A (en) | Traditional Chinese medicine for preventing and treating ischemic cardiovascular and cerebrovascular diseases | |
CN106421581A (en) | Biological traditional Chinese medicine for oral administration for treating diabetes and preparation method thereof | |
CN102008688B (en) | Medicament for treating periodic psychosis | |
CN109922816A (en) | Composition comprising pollen and/or gynoecium extract, its preparation process and associated uses | |
CN102487974A (en) | Kelp micro powder lotus seed paste | |
CN102552724B (en) | Chinese medicine composite for curing hypertension | |
CN102139005B (en) | Medicine for treating cardiovascular and cerebrovascular diseases | |
CN101249236B (en) | Chinese and western medicine combined preparations for curing epileptic | |
CN104643076A (en) | Blood-glucose reducing health product containing folium mori main active ingredient | |
JP2016515613A (en) | A composition for improving the health and quality of life of women, containing ginseng seed extract | |
CN102657716A (en) | Anti-aging traditional Chinese medicine composition and preparation method thereof | |
CN103704698B (en) | A kind of lactation-promoting health-care food granules and preparation method thereof | |
CN103341015B (en) | Medicine for treating three-highs and preparation method thereof | |
CN108721489A (en) | Tranquilizing the mind pomander and preparation method thereof | |
CN102526377B (en) | Chinese medicinal herb tea for contributing to cardiovascular and cerebrovascular diseases and promoting sleeping and preparation method thereof | |
CN106511544A (en) | Composition for reducing blood glucose and application of composition | |
CN102526612B (en) | Traditional Chinese medicine composite for curing angina pectoris | |
CN102120009A (en) | Prunella vulgaris capsule capable of stabilizing blood pressure |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150121 Termination date: 20160428 |